A
Amire focuses on accelerating the availability of cancer treatments utilizing alpha radioisotopes for enhanced efficacy. This targeted alpha radiation offers superior precision compared to beta radiation, minimizing collateral damage to healthy tissues. The therapy aims to decrease cancer recurrence likelihood through high linear energy transfer, often requiring only three minimally invasive syringe administrations.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Amire focuses on accelerating the availability of cancer treatments utilizing alpha radioisotopes for enhanced efficacy. This targeted alpha radiation offers superior precision compared to beta radiation, minimizing collateral damage to healthy tissues. The therapy aims to decrease cancer recurrence likelihood through high linear energy transfer, often requiring only three minimally invasive syringe administrations.